Buy & Sell Alnylam Pharmaceuticals, Inc. (ALNY) – Alnylam Pharmaceuticals, Inc. Price Today
Aura AI Summary
Key Stats
- $39.26BMarket Cap
- HealthSector
- -18.07%3M Drawdown
- $37.52BEnterprise Value
- -Dividend Yield
- 42 daysTypical Hold Time
Alnylam Pharmaceuticals, Inc. (ALNY) is currently valued at a market capitalization of $39.26B, with an enterprise value of $37.52B. Over the past 52 weeks, Alnylam Pharmaceuticals, Inc. has traded between a low of $278.09 and a high of $491.22, highlighting its annual price range. Over the past three months, Alnylam Pharmaceuticals, Inc. has recorded a drawdown of -18.07%, reflecting recent price volatility. On average, investors hold Alnylam Pharmaceuticals, Inc. for approximately 42 days, indicating typical investor behavior on the platform.
About Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia.
Most Recent News
Arbitration confirms SCOR's retrocession treaties with Covéa, awarding $488.3M compensation.
SCOR announced that an arbitration tribunal upheld the validity of retrocession treaties made with Covéa in June 2021, involving the transfer of 30% of SCOR's Life & Health portfolio in Ireland. The tribunal awarded Covéa compensation of USD 488.3 mi...

Titan Mining to build first U.S. military graphite purification plant, cutting reliance on China.
Titan Mining's subsidiary Empire State Mines has been conditionally selected by the U.S. Army to develop the first-ever commercial graphite purification facility on U.S. military bases at Pine Bluff Arsenal, Arkansas, and Anniston Army Depot, Alabama...

MEDIROM triples deployment of REMONY® health monitoring system in Japan Ground Self-Defense Force 8th Division.
MEDIROM MOTHER Labs has expanded its deployment of the REMONY® remote health monitoring system, equipped with the recharge-free MOTHER Bracelet®, in the Japan Ground Self-Defense Force (JGSDF) 8th Division. The additional order triples the scale of t...
